Liver disease in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 6, 2011, Pages 461-466

  Rowland, Marion ^a   Bourke, Billy ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

animal models; cystic fibrosis liver disease; liver transplantation; outcome; phenotype

Indexed keywords

PROTEIN SERPINA1; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

BODY COMPOSITION; CYSTIC FIBROSIS LIVER DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG EFFICACY; ECHOGRAPHY; ELASTOGRAPHY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; LIFE EXPECTANCY; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LUNG FIBROSIS; MORTALITY; NONHUMAN; NUTRITION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHENOTYPE; PORTAL HYPERTENSION; REVIEW; RISK FACTOR;

ANIMALS; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; FEMALE; FERRETS; HUMANS; LIVER DISEASES; MALE; NUTRITIONAL STATUS; PHENOTYPE; RISK FACTORS; SWINE;

EID: 80053378342     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834b7f51     Document Type: Review

References (32)

1. Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010; 1:69-84.
2. OSullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373:1891-1904.
3. Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007; 56:1153-1163. (Pubitemid 47123248)
4. Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med 2007; 13:529-536. (Pubitemid 47494203)
5. Arnon R, Annunziato RA, Miloh T, et al. Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database. Pediatr Transplant 2011; 15:254-264.
6. Corbett K, Kelleher S, Rowland M, et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr 2004; 145:327-332. (Pubitemid 39165680)
7. Gooding I, Dondos V, Gyi KM, et al. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl 2005; 11:1522-1526. (Pubitemid 43072628)
8. Potter CJ, Fishbein M, Hammond S, et al. Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? J Pediatr Gastroenterol Nutr 1997; 25:32-36. (Pubitemid 27284282)
9. Lewindon PJ, Shepherd RW, Walsh MJ, et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011; 53:193-201.
10. Mueller-Abt PR, Frawley KJ, Greer RM, Lewindon PJ. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. J Cyst Fibros 2008; 7:215-221. (Pubitemid 351650268)
11. Witters P, De Boeck K, Dupont L, et al. Noninvasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros 2009; 8:392-399.
12. Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis: transient elastography and cystic fibrosis. J Cyst Fibros [Epub ahead of print]. doi: 10.1016/j.jcf20111.04.004.
13. Menten R, Leonard A, Clapuyt P, et al. Transient elastography in patients with cystic fibrosis. Pediatr Radiol 2010; 40:1231-1235.
14. Bartlett JR, Friedman KJ, Ling SC, et al. Genetic modifiers of liver disease in cystic fibrosis. J Am Med Assoc 2009; 302:1076-1083.
15. de Haan W. A marker associated with increased risk for severe liver disease in cystic fibrosis. Clin Genet 2010; 77:434-437.
16. Frangolias DD, Ruan J, Wilcox PJ, et al. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. Am J Respir Cell Mol Biol 2003; 29:390-396. (Pubitemid 37093998)
17. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991; 66:698-701.
18. Nash KL, Allison ME, McKeon D, et al. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cyst Fibros 2008; 7:252-257.
19. Rowland M, Gallagher CG, OLaoide R, et al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011; 106:104-109.
20. Chamnan P, Shine BS, Haworth CS, et al. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010; 33:311-316.
21. Witters P, Libbrecht L, Roskams T, et al. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology 2011; 53:1064-1065.
22. Lewindon PJ, Ramm GA. Cystic fibrosis-cirrhosis, portal hypertension, and liver biopsy: reply. Hepatology 2011; 53:1065-1066.
23. Rogers CS, Hao Y, Rokhlina T, et al. Production of CFTR-null and CFTRDeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 2008; 118: 1571-1577. (Pubitemid 351500450)
24. Rogers CS, Stoltz DA, Meyerholz DK, et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 2008; 321:1837-1841.
25. Sun X, Sui H, Fisher JT, et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 2010; 120:3149-3160.
26. Meyerholz DK, Stoltz DA, Pezzulo AA, Welsh MJ. Pathology of gastrointestinal organs in a porcine model of cystic fibrosis. Am J Pathol 2010; 176:1377-1389.
27. Rogan MP, Reznikov LR, Pezzulo AA, et al. Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth. Proc Natl Acad Sci U S A 2010; 107:20571-20575.
28. Freudenberg F, Broderick AL, Yu BB, et al. Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model. Am J Physiol Gastrointest Liver Physiol 2008; 294:G1411-G1420.
29. Siano M, De Gregorio F, Boggia B, et al. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Dig Liver Dis 2010; 42:428-431.
30. Lu BR, Esquivel CO. A review of abdominal organ transplantation in cystic fibrosis. Pediatr Transplant 2010; 14:954-960.
31. Nightingale S, OLoughlin EV, Dorney SF, et al. Isolated liver transplantation in children with cystic fibrosis: an Australian experience. Pediatr Transplant 2010; 14:779-785.
32. Nash EF, Volling C,Gutierrez CA, et al.Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant [Epub ahead of print]. doi: 10.1111/j.1399-0012.2010.01395.x.